#
# This is a Shiny web application. You can run the application by clicking
# the 'Run App' button above.
#
# Find out more about building applications with Shiny here:
#
#    http://shiny.rstudio.com/
#

library(shiny)
library(shinydashboard)
library(shinydashboardPlus)

source("~/MassTesting/buildFigures.R")



# Define UI for application that draws a histogram
ui <- navbarPage("Frequent PCR Testing for Airborne Pathogens",
   

   tabsetPanel(
     tabPanel(
       "Intervention Effectiveness",
       # Sidebar with a slider input for number of bins 
       sidebarLayout(
          sidebarPanel(
             sliderInput("testDelay",
                         "Test Delay [hours]:",
                         min = 0,
                         max = 72,
                         value = 24),
             #sliderInput("contactsPerDay","Contacts Per Day:", min = 0,max = 40,value = 13),
              sliderInput("fracTest","Fraction of population regularly testing:", min = 0,max = 0.995,value = 0.90),
             sliderInput("fracIso","Fraction of transmissions prevented by isolation:", min = 0,max = 0.995,value = 0.90),
             checkboxGroupInput("testPeriods", "Days Between Tests", choices = list(1, 2,3,5,7,10,30), selected= (list(1,3,7)), inline = TRUE),
             sliderInput("maskEffect","Fraction of transmissions prevented by masks:", min = 0,max = 0.995,value = 0.0),
             h3("Calculation details:"),
             p("ùõæ: Fraction of (homogeneous) population testing regularly
               ùõΩ: Isolation effectiveness (fraction reduction in transmissions for detected positives)
               ùúé: Fraction of counterfactual transmissions occurring after receiving a positive test result
               ")
             ),
          
          # Show a plot of the generated distribution
          mainPanel(
             plotOutput("controlRegion", height="550px"),
             h2("Motivation"),
             p("Novel airborne pandemic with no available vaccines or treatments"),
             p("Global elimination unlikely, so expecting imported cases (even with strong border controls)"),
             p("\nGoal: reduce infections while waiting for vaccines"),
             p("Challenge: because of the high cost of existing NPIs, many countries may be unwilling or unable to control the epidemic"),
             p("Proposed solution: frequent saliva PCR testing for most of the population")
             
             #Todo: show peak image with peak viral load and time to peak, describe how figure generated
          )
       )
      ),
     tabPanel(
       "Viral Model",
       sidebarLayout(
         sidebarPanel(

           sliderInput("minLogPCRViralLoad","Minimum viral load (log10 copies / ml) for PCR detection :", min = 0,max = 6,value = 3), 
           plotOutput("TestSensitivity", height="130px"),
           
           sliderInput("maxProbTransmitPerExposure","Maximum Probability of Transmission Per Exposure:", min = 0.1,max = 0.9,value = 0.3), # 0.3 would be consistent with 95% of measles household contacts infected -> 1 - 0.7^8 = 0.94
           sliderInput("contactsPerDay","Contacts per day:", min = 1,max = 50,value = 13), 
           
           plotOutput("Infectiousness", height="130px"),
           sliderInput("relativeDeclineSlope","Relative Slope of Viral Decline:", min = 0.1,max = 3.0,value = 1.0),
           sliderInput("maxDaysAfterPeak","Maximum Number of days after peak \n viral load that infection ends:", min = 0,max = 20,value = 30),
           # todo: computation of expected transmissions after postive test

           # sliderInput("simPrecision","Simulation Precision:", min = 0,max = 1,value = 0.2)
           
         ),
         mainPanel(
           p("A pathogen can be characterized by its viral load trajectory: specifically the peak viral load and the time taken to reach the peak."),
           # todo: figure of characteristic curve
           p("The expected daily transmissions and PCR sensitivity can be estimated using the mappings in the sidebar"),
           p("By averaging over test timing offsets and test outcomes, the fraction of counterfactual transmissions occuring after a positive test can be computed for each testing strategy."),
           
           
           
           plotOutput("Trajectories", height="500px")
           #Todo: Add figures for fraction of transmissions occuring after positive test for each trajectory
           
         )
         
       )
     ),
     tabPanel(
       "Economic Cost",   
       sidebarLayout(
         sidebarPanel(
           sliderInput("variableTestCost","Variable Cost Per Test (USD):", min = 1,max = 100,value = 10),
           sliderInput("isolationCost","Cost of supporting case isolation:", min = 0,max = 50000,value = 5000),
          
           sliderInput("fixedAnnualizedDailyTestCost","Annual Fixed Cost per Daily Test Capability:", min = 0.01,max = 10,value = 0.28)
           
         ),
         mainPanel(
           plotOutput("PrevalenceCost", height="500px")
           # todo: add as function of import rate (with targeted strategies as an option)
           # Todo: add sources for fixed and variable costs
         )
         
       )

       

      
      ),
     tabPanel(
       "Example Implementation", 
       p("
        
         There are a few modifications that could im- prove the likelihood of achieving this support: reduced cost (as previously discussed), less authoritarian-seeming rules (to be discussed shortly) and increasing the pleasantness of the testing experience. 
To improve the testing experience, gargle [190, 191] or saliva tests could be used instead of nasal swabs 4 and time spent waiting at or traveling to testing sites could be reduced

         A more difficult part of the design is deciding on tradeoffs between robustness to non- compliance and authoritarian capabilities (or the perception of them). It is much easier to enforce participation for things that the public believes are necessary and important. 
In a mass testing deployment, there are two critical steps that depend on the population: 1) frequent testing and 2) effective isolation if positive. 
The honor system may be too optimistic, but both steps have not- too-excessive methods of enforcement. Frequent testing could be encouraged by requiring proof of a recent negative test to enter public spaces. 
Isolation at home can be subject to random check-ins with fines to discourage non-compliance.

      
        It seems like nasal and gargle tests have comparable sensitivity for COVID-19 [191]. Even if more pleasant testing was 10-20% less sensitive, this could be still be worthwhile if it improves public support.
         
         outside of a few countries . However, support for a mass-testing approach may be greater when faced with a novel deadly pandemic. 
There are a few modifications that could im- prove the likelihood of achieving this support: reduced cost (as previously discussed), less authoritarian-seeming rules (to be discussed shortly) and increasing the pleasantness of the testing experience. 
To improve the testing experience, gargle [190, 191] or saliva tests could be used instead of nasal swabs 4 and time spent waiting at or traveling to testing sites could be reduced.
         
         Another area to be careful about is the validity of test results ‚Äì whether tests are being taken properly and by the right people. For example, self-serving people who suspect they could be infected have an incentive to not test properly. 
A robust system will preferably have the ability to detect this failure mode and adjust if it became a significant problem. 
For this reason, designs where the sample collection process can be observed are prefer- able. 
Having testing records securely stored and associated with people‚Äôs identity makes understanding the disease easier for public health departments and researchers. 
However, in some countries requiring this may decrease public support and disincentivize participa- tion among some populations (undocumented immigrants, libertarians, etc.). 
A potential solution is to offer anonymous testing but heavily incentivize5 a version that associates test results with a person‚Äôs health record.
         Based on these considerations, the following is a potential implementation:
         1. Sample collection sites easily available ‚Äì unstaffed, in style of self-checkout kiosks6
         2. Gargle or saliva-based sampling, with detachable QR code to get test results later
         3. Scalable service like Uber or Amazon delivery frequently picks up samples7
         4. Highly automated8 labs perform PCR tests
         5. Results posted to public database linked to QR codes (ideally within 8 hours of collection)
         6. QR code demonstrating a recent negative test permits entry into public spaces
         7. Peoplewhotestpositivearerequiredbylawtoeffectivelyisolate‚Äìfreetransportation, financial support, food, and accommodation provided if needed
         The likelihood of success for a mass-testing intervention (as with most NPIs) increases with the ability to detect, diagnose, and adapt to failure modes. 
In this case, some impor- tant areas to monitor are isolation effectiveness, testing compliance, and the frequency of transmissions occurring before testing positive. This proposal is based on several partially
         5For example, allowing entry into public spaces immediately after testing instead of waiting for test results
         6Potentially with a cheap camera to discourage sabotage or intentionally testing incorrectly
         7With option of testing at home for those with accessibility issues, symptoms, or who wish to pay for it
         8Potentially more innovation needed to make this scalable and cheap 134
         
         validated assumptions, which ideally can be strengthened with further analysis, numerical modeling, wargaming [192], and real-world experiments. 
         While preliminary, it offers some optimism that innovation can enable an acceptable compromise between civil liberties and robust disease control."
         )
       
     ),
     
     tabPanel(
       
       "Potential Challenges",
       accordion(
         id = "accordion1",
         accordionItem(
           title = "speed for pathogens with short generation time",
           collapsed = TRUE,
           "- sol: reduce pcr delay time - sol: add household quarantine or some contact tracing"
         ),
         accordionItem(
           title = "enforcing isolation and testing",
           collapsed = TRUE,
           "- sol: require testing for daily activities
         - sol: validate isolation being followed, and generously support it
           - response: for many spillover pathogens, R0 is initially fairly low, so even partial adherence may be enough
           - response: for higher R0 pathogens, partially effective mass testing substitutes for more expensive social distancing"
         ),
         accordionItem(
           title = "early pandemic time to functionality (materials, personnel, equipment, logistics)",
           collapsed = TRUE,
           "sol: more analysis of failure modes
         - sol: run peacetime simulation excercises"
         ),
         accordionItem(
           title = "accuracy of viral load/infectiosness/pcr model for novel pathogens",
           collapsed = TRUE,
           "argument: many common
         - argument: PCR is fairly well understood -if the RNA is there at a certain concentration it can be found"
         ),
         accordionItem(
           title = "running cost too high",
           collapsed = TRUE,
           "sol: reduce testing frequency in areas with low chance of infections
         - sol: automate further, develop own reagents"
         ),
         accordionItem(
           title = "population behaviour in different pandemic scenarios",
           collapsed = TRUE,
           "sol for seemingly low IFR: reduce cost and burden of response
         - sol for high IFR: keep prevalence very low, have sufficient PPE"
         ),
         accordionItem(
           title = "heterogeneous population behavioiur",
           collapsed = TRUE,
           "sol: feedback mechanisms to find and respond to process failures"
         )
       )
       
     ),
     
     tabPanel("Related Work",
              p("Mass testing deployments in western countries have been limited in time or the fraction
of the population participating (e.g. Slovakia testing the whole population twice, but not on
                an ongoing basis [188]). The expense of massively scaling testing was likely a contributing
                factor preventing more widespread deployment. The limited scope of deployment limited
                the possible success because people testing regularly could still be infected by members of
                the broader community, and cases could rebound after time-limited interventions.
                
                For the original COVID-19 variant, Elbanna and Goldenfeld estimated that testing twice a week would be sufficient to bring Rt below 1 (assuming perfect isolation of those who test positive)
                
                Mass testing seems to be an important component of China‚Äôs ‚Äúdynamic Covid-zero‚Äù
policy (as of July 2022). The independent effect of mass testing is difficult to estimate
                because they are using it in combination with a few other strategies like venue based trac-
                ing and localized lockdowns. The combined approach seems to be effective at containing
                outbreaks, but it is difficult to determine what the cost of this is
                
                ")
              
              ),
     tabPanel("Policy Proposal",
              h3("1) Build enough PCR equipment in advance to be able to test every person every day during a pandemic"),
              p(""),
              h3("2) Incorporate mass testing into national pandemic response plans"),
              h3("3) Regularly perform simulation excercises to test system readiness")
              )
     
     # tabPanel(
     #    "Outbreak Model"
     #    # 2 compartment SIR model -inside and outside region
     #    # outside not controlled much
     #    # inside applies border control at a certain time that prevents _% of infected cases entering
     #    # applies mass testing at another time
     #    # parameterized by normal number of travelers, viral parameters, type of intervention
     #    
     #    # show cumulative cost and cumulative infections over time.
     #    # show fraction infected over time
     #    # add ability for temporary lockdown?
     #    
     #  ),


   )
)

# Define server logic required to draw a histogram
server <- function(input, output) {
   
   output$controlRegion <- renderPlot({
     
     #input$contactsPerDay
     inputParams = c(contactsPerHour = input$contactsPerDay/24, testDelay = input$testDelay, fracIso = input$fracIso, fracTest = input$fracTest, 
                     precision = 0.2, maxProbTransmitPerExposure = input$maxProbTransmitPerExposure,
                     relativeDeclineSlope = input$relativeDeclineSlope, maxTimeAfterPeak = 24*input$maxDaysAfterPeak, maskEffect = input$maskEffect, minLogPCRViralLoad = input$minLogPCRViralLoad)
     
     generateControllabilityFigure(24*as.numeric(input$testPeriods), inputParams)
     
     
    })
   
   output$Trajectories <- renderPlot({
     #reactive({
       #req(getIncperMedianlogContour()) # can't plot it until these values have been calculated
        
     inputParams = c( logPeakLoad = 10, contactsPerHour = input$contactsPerDay/24, maxProbTransmitPerExposure = input$maxProbTransmitPerExposure, relativeDeclineSlope = input$relativeDeclineSlope, maxTimeAfterPeak = 24*input$maxDaysAfterPeak, minLogPCRViralLoad = input$minLogPCRViralLoad)
     
      plotTrajectories(inputParams) 
       
    # })
   })
   
   output$Infectiousness <- renderPlot({
     inputParams = c(contactsPerHour = input$contactsPerDay/24, maxProbTransmitPerExposure = input$maxProbTransmitPerExposure, relativeDeclineSlope = input$relativeDeclineSlope, maxTimeAfterPeak = 24*input$maxDaysAfterPeak)
     plotInfectiousness(inputParams) 
   })
   output$TestSensitivity <- renderPlot({
     inputParams = c(contactsPerHour = input$contactsPerDay/24, maxProbTransmitPerExposure = input$maxProbTransmitPerExposure, relativeDeclineSlope = input$relativeDeclineSlope, maxTimeAfterPeak = 24*input$maxDaysAfterPeak, minLogPCRViralLoad = input$minLogPCRViralLoad)
     plotTestSensitivity(inputParams) 
   })

   output$PrevalenceCost <- renderPlot({
     inputParams = c(variableTestCost = input$variableTestCost, isolationCost = input$isolationCost, fixedAnnualizedDailyTestCost = input$fixedAnnualizedDailyTestCost)
     plotPrevalenceCost(as.numeric(input$testPeriods), inputParams) 
   })   
}

# Run the application 
shinyApp(ui = ui, server = server)

